Marcela Stewart currently serves as an Account Executive in Oncology Sales at Genpath Diagnostics, a division of BioReference Laboratories, where she leverages her extensive expertise in laboratory medicine and anatomic pathology to drive business development and enhance client relationships. With a strong focus on personalized...
Marcela Stewart currently serves as an Account Executive in Oncology Sales at Genpath Diagnostics, a division of BioReference Laboratories, where she leverages her extensive expertise in laboratory medicine and anatomic pathology to drive business development and enhance client relationships. With a strong focus on personalized genetic medicine, Marcela is dedicated to providing innovative solutions that empower genomics laboratories. Her role involves not only promoting advanced next-generation sequencing (NGS) testing but also ensuring that healthcare providers have access to reliable data analysis that can significantly impact patient outcomes.
In her position, Marcela is actively engaged in key projects that aim to streamline the integration of immunohistochemistry and microscopy techniques into routine cancer diagnostics. By collaborating closely with hospitals and laboratories, she helps facilitate the adoption of cutting-edge technologies that enhance cancer detection and treatment strategies. Her attention to detail and deep understanding of cell biology allow her to effectively communicate the benefits of Genpath's offerings to oncologists and pathologists, ensuring they have the tools necessary for accurate diagnoses and personalized treatment plans.
Marcela's previous experience as a Pathology Manager at CHI Baylor St. Luke's in the Texas Medical Center has equipped her with a unique perspective on the challenges faced by healthcare providers in the oncology space. This background, combined with her passion for advancing the field of personalized medicine, positions her as a valuable resource for clients navigating the complexities of cancer care. Through her commitment to excellence and innovation, Marcela Stewart is making significant strides in the realm of oncology diagnostics, ultimately contributing to improved patient outcomes in the fight against cancer.
